Latest Blogs

Oct 17, 2019
A famous castle in Byblos was illuminated pink in honor of Breast Cancer Awareness Month as cancer care professionals spoke out about screening and early detection.
Oct 08, 2019
I wondered how my mentor felt on the topic of personal and professional, on whether it is a good idea to allow a look into the person behind the white coat.
Oct 03, 2019
As physicians, we have a responsibility to our patients in the clinic and in the ballot box. Ms. Talya Laufer and I advocate for a politically engaged and informed medical workforce. 
Sep 26, 2019
Physician parents worry about the effect of their long hours and work commitments on their children. Dr. Sayeh Lavasani suggests focusing on the positive lessons you are modeling for them.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Oct 16, 2019
Participants in ASCO's Advocacy Summit discuss the importance of being engaged with health policy to improve the lives of people affected by cancer.
Oct 04, 2019
About 42 million Medicaid patients do not have the guaranteed ability to participate in clinical trials.
May 20, 2019
Dr. Ward and I discuss the policies that public and private insurers use to control the use of anticancer drug therapies, such as prior authorization requirements, restrictive formularies, step therapy, or fail first requirements, and specialty specific tiers.
Mar 26, 2019
Dr. Sharpless joined me to talk about pediatric cancer research, clinical trial methodology, eligibility criteria, and more.
Mar 11, 2019
For many of us not a day has gone by without some reminder of Arti, but last week brought it all back into sharp focus as I was asked to talk about the role we at ASCO played in her career during a symposium in her honor.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.

Pages